Key result
Aripiprazole blocked Kv1.4 potassium channels in a concentration-dependent manner with an IC50 value of 4.4 μM, indicating preferential binding to the open state of the channels.
Why the study?
Although aripiprazole is relatively safe in cardiac ailments, little is known about its effects on voltage-gated ion channels like transient A-type K+ channels.
Effect estimate: IC50 4.4 μM
Aripiprazole blocks A-type potassium channels (Kv1.4 and Kv4.3) in the open state, which may provide an ionic basis for its cardiac and neurological electrophysiological effects.
May influence cardiac electrophysiology with aripiprazole use; leaves open clinical arrhythmia relevance.
Aripiprazole is a quinolinone derivative approved as an atypical antipsychotic drug for the treatment of schizophrenia and bipolar disorder. It acts as with partial agonist activities at the dopamine D2 receptors. Although it is known to be relatively safe for patients with cardiac ailments, less is known about the effect of aripiprazole on voltage-gated ion channels such as transient A-type K + channels, which are important for the repolarization of cardiac and neuronal action potentials. Here, we investigated the effects of aripiprazole on Kv1.4 currents expressed in HEK293 cells using a whole-cell patch-clamp technique. Aripiprazole blocked Kv1.4 channels in a concentration-dependent manner with an IC 50 value of 4.4 M and a Hill coefficient of 2.5. Aripiprazole also accelerated the activation (time-to-peak) and inactivation kinetics. Aripiprazole induced a voltage-dependent ( = 0.17) inhibition, which was use-dependent with successive pulses on Kv1.4 currents without altering the time course of recovery from inactivation. Dehydroaripiprazole, an active metabolite of aripiprazole, inhibited Kv1.4 with an IC 50 value of 6.3 M (p < 0.05 compared with aripiprazole) with a Hill coefficient of 2.0. Furthermore, aripiprazole inhibited Kv4.3 currents to a similar extent in a concentration-dependent manner with an IC 50 value of 4.9 M and a Hill coefficient of 2.3. Thus, our results indicate that aripiprazole blocked Kv1.4 by preferentially binding to the open state of the channels.
No takes yet. Share an insight, caveat, or question.
Park et al. (2020) studied this question. Aripiprazole vs. Control (absence of aripiprazole) was evaluated on Inhibition of Kv1.4 currents (IC50 4.4 μM). Aripiprazole blocked Kv1.4 potassium channels in a concentration-dependent manner with an IC50 value of 4.4 μM, indicating preferential binding to the open state of the channels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: